XORTX Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -33 | -31 | -16 | |
EBITDA | -1,460 | -1,051 | -1,373 | |
EBIT | -1,493 | -1,083 | -1,389 | |
Net Income | 170 | -3,005 | 2,699 | -1,333 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -749 | -1,300 | -1,307 | -1,078 |
Cash | 3,078 | 3,831 | 3,447 | 5,069 |
Basic Shares | 2,903 | 2,429 | 1,998 | 1,998 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -6,468 | -10,632 | -4,121 | -1,280 |
EBIT | -6,566 | -10,687 | -4,135 | -1,296 |
Net Income | -2,859 | -6,988 | -1,295 | -1,284 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,629 | -8,862 | -4,786 | -742 |
Cash | 3,447 | 10,407 | 14,785 | 171 |
Basic Shares | 1,981 | 1,479 | 1,094 | 740 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | $0.05 |
2024-03-31 | $1.35 |
2023-09-30 | -$0.67 |
2023-06-30 | -$0.80 |
